Functional and Neurochemical Brain Changes Following Successful Treatment of Early Course Bipolar Depression.

Trial Profile

Functional and Neurochemical Brain Changes Following Successful Treatment of Early Course Bipolar Depression.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Dec 2013

At a glance

  • Drugs Lithium (Primary) ; Quetiapine (Primary)
  • Indications Bipolar I disorders
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Feb 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 18 Feb 2009.
    • 08 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top